Aptar Pharma will launch eDose Counter for MDIs Integrating a Proprietary Sensing Technology at CPHI/ICSE Europe Barcelona 2016.

September 27, 2016



Aptar Pharma eDose Counter for metered dose inhalers (MDIs)

 

Aptar Pharma will unveil its eDose Counter for metered dose inhalers (MDIs) at the CPHI/ICSE Europe tradeshow to be held on October 4-6, in Barcelona.

 

Our patented eDose Counter for MDIs is designed to be easy-to-use and reliable, and contributes to patient compliance.

 

Our unique sensing technology offers direct detection of the spray which eliminates risks of miscounting.

 

The sensing technology is versatile and compatible with any metering valve design. In addition, our eDose Counter for MDIs includes inhaler priming and medication reminders-to-use and end-of-product-life warnings (flashing digits) while remaining cost-effective.

 

For further details on eDose Counter for MDIs, please visit our booth #2M18, Hall 2 (Innopack area) and liaise with Chris Baron, our Associate Director Business Development: chris.baron@aptar.com, or visit our website at aptar.com/pharma.